27/05/2022 |
08:20 to 10:50 |
Myelodysplastic
syndromes (MDS) |
08:40 to 09:00 |
Bringing AML approaches to high-risk SMD. Is it
working? |
Speaker |
27/05/2022 |
08:20 to 10:50 |
Myelodysplastic
syndromes (MDS) |
09:00 to 09:20 |
How is the great barrier of highly resistant
myeloid neoplasms being overcome? Learn how it is being done |
Speaker |
27/05/2022 |
08:20 to 10:50 |
Myelodysplastic
syndromes (MDS) |
09:40 to 10:00 |
When low-risk MDS behaves badly |
Speaker |
27/05/2022 |
08:20 to 10:50 |
Myelodysplastic
syndromes (MDS) |
10:20 to 10:50 |
Q&A |
Discussant |